Conclusion:-
In conclusion, Takayasu arteritis presents with a heterogeneous clinical profile, involving multiple organ systems. The non-specific nature of symptoms and the potential overlap with other conditions pose challenges for diagnosis. It is crucial for clinicians to maintain a high index of suspicion, particularly in young females presenting with symptoms such as headache, vision problems, dizziness, and upper extremity fatigue. Early recognition, appropriate diagnostic evaluation, and timely initiation of treatment are paramount to improve patient outcomes and prevent complications associated with Takayasu arteritis. Further research is needed to enhance our understanding of the disease and develop more effective diagnostic and treatment strategies.
REFERENCES:-
1. De Souza AWS, de Carvalho JF. Diagnostic and classification criteria of Takayasu arteritis. J Autoimmun . 2014;48-49:79-83. doi:10.1016/J.JAUT.2014.01.012
2. Mason JC. Takayasu arteritis–advances in diagnosis and management.Nat Rev Rheumatol . 2010;6(7):406-415. doi:10.1038/NRRHEUM.2010.82
3. Nakagomi D, Jayne D. Outcome assessment in Takayasu arteritis.Rheumatology . 2016;55(7):1159-1171. doi:10.1093/RHEUMATOLOGY/KEV366
4. Lupi-Herrera E, Sánchez-Torres G, Marcushamer J, Mispireta J, Horwitz S, Espino Vela J. Takayasu’s arteritis. Clinical study of 107 cases.Am Heart J . 1977;93(1):94-103. doi:10.1016/S0002-8703(77)80178-6
5. Subramanyan R, Joy J, Balakrishnan KG. Natural history of aortoarteritis (Takayasu’s disease). Circulation . 1989;80(3):429-437. doi:10.1161/01.CIR.80.3.429
6. Hall S, Barr W, Lie JT, Stanson AW, Kazmier FJ, Hunder GG. Takayasu arteritis. A study of 32 North American patients. Medicine (Baltimore) . 1985;64(2):89-99. doi:10.1097/00005792-198503000-00002
7. Kerr GS, Hallahan CW, Giordano J, et al. Takayasu arteritis.Ann Intern Med . 1994;120(11):919-929. doi:10.7326/0003-4819-120-11-199406010-00004
8. Jain S, Kumari S, Ganguly NK, Sharma BK. Current status of Takayasu arteritis in India. Int J Cardiol . 1996;54 Suppl(S2):S111-S116. doi:10.1016/S0167-5273(96)88780-8
9. Mwipatayi BP, Jeffery PC, Beningfield SJ, et al. Takayasu arteritis: clinical features and management: report of 272 cases. ANZ J Surg . 2005;75(3):110-117. doi:10.1111/J.1445-2197.2005.03312.X
10. Andrews J, Mason JC. Takayasu’s arteritis–recent advances in imaging offer promise. Rheumatology (Oxford) . 2007;46(1):6-15. doi:10.1093/RHEUMATOLOGY/KEL323
11. Blockmans D, Bley T, Schmidt W. Imaging for large-vessel vasculitis.Curr Opin Rheumatol . 2009;21(1):19-28. doi:10.1097/BOR.0B013E32831CEC7B
12. Meller J, Strutz F, Siefker U, et al. Early diagnosis and follow-up of aortitis with [(18)F]FDG PET and MRI. Eur J Nucl Med Mol Imaging . 2003;30(5):730-736. doi:10.1007/S00259-003-1144-Y
13. Andrews J, Al-Nahhas A, Pennell DJ, et al. Non-invasive imaging in the diagnosis and management of Takayasu’s arteritis. Ann Rheum Dis . 2004;63(8):995-1000. doi:10.1136/ARD.2003.015701
14. Ito I. Medical treatment of Takayasu arteritis. Heart Vessels Suppl . 1992;7(1 Supplement):133-137. doi:10.1007/BF01744559
15. Hoffman GS. Takayasu arteritis: lessons from the American National Institutes of Health experience. Int J Cardiol . 1996;54 Suppl(S2):S99-S102. doi:10.1016/S0167-5273(96)88778-X
16. Hoffman GS, Ahmed AE. Surrogate markers of disease activity in patients with Takayasu arteritis. A preliminary report from The International Network for the Study of the Systemic Vasculitides (INSSYS). Int J Cardiol . 1998;66 Suppl 1(SUPPL. 1). doi:10.1016/S0167-5273(98)00181-8
17. Noel N, Butel N, Le Hoang P, et al. Small vessel involvement in Takayasu’s arteritis. Autoimmun Rev . 2013;12(3):355-362. doi:10.1016/J.AUTREV.2012.05.010